European Medicines Agency Validates Marketing Authorisation Application for ZINBRYTA™ (Daclizumab High-Yield Process) for Treatment of MS
Biogen, 27 Mar 2015
Accessed on 7 Apr 2015 from http://biogen.newshq.businesswire.com/press-release/corporate/european-medicines-agency-validates-marketing-authorisation-application-zinb.